| Name | Title | Contact Details |
|---|
Laurels Of Norworth is a Worthington, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Diamond Healthcare Corporation is the national leader in the planning, development and operation of high quality Behavioral Health Services in partnership with healthcare organizations. Diamond`s client relationships span a diverse geographic and demographic range — from rural critical access hospitals to urban academic medical centers, from sole community hospitals to multi-hospital health systems, including faith-based healthcare organizations, not-for-profit systems and for-profit hospital companies. Diamond offers a comprehensive range of healthcare services.
Catholic Health Services is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.